|
Objective: To observe the treatment of kidney Huatanquyu hyperlipidemia clinical efficacy , and to explore its mechanism . Methods: A randomized approach that will meet the inclusion criteria , 60 patients with hyperlipidemia were divided into treatment and control groups , each group of 30 people. The treatment group received simvastatin 10mg daily lipid Tonga ; control group , the use of simvastatin 20mg daily . 4 weeks for a course of treatment. Detected in patients before and after treatment lipids, activated partial thromboplastin time , prothrombin time , international normalized ratio , fibrinogen, and other biochemical markers and changes in patient symptoms . Results: The total effective rate of symptom improvement 86.67% effective rate is 40.00% , compared with the control group, there were significant differences (P lt; 0.05); treatment group TC, LDL-C, TG significantly reduced , HDL- C, ApoA1 increased significantly compared with the control group had no significant difference (P gt; 0.05); treatment group ApoB, Lp (a), Fg decreased , APTT, PT increased significantly compared with the control group , there were significant difference (P lt; 0.05 or 0.01 ) . Conclusion: Treatment of phlegm stasis method is an effective method of hyperlipidemia , and has improved hypercoagulable states , to prevent thrombosis function.
|